Novavax, Inc. Share Price
NVAXNovavax, Inc. Stock Performance
Open $8.04 | Prev. Close $7.87 | Circuit Range N/A |
Day Range $7.85 - $8.05 | Year Range $5.01 - $10.64 | Volume 65,878 |
Average Traded $7.93 |
Novavax, Inc. Share Price Chart
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Feb-26 | $8.57 | $8.28 | -1.08% |
03-Feb-26 | $8.72 | $8.37 | -3.68% |
02-Feb-26 | $8.65 | $8.69 | -1.81% |
30-Jan-26 | $9.27 | $8.85 | -6.25% |
29-Jan-26 | $9.36 | $9.44 | +2.39% |
28-Jan-26 | $9.79 | $9.22 | -6.01% |
27-Jan-26 | $9.77 | $9.81 | +1.92% |